All oligosaccharide moieties of the μ chains in the pre-BCR are of the high-mannose type

Molecular Immunology

Volumn 48, Issue 1-3, 2010, Pages 351-355

  Haimovich, Joseph ^a   Moshe, Natalie Ben ^a   Raviv, Yasmin ^a   Hollander, Nurit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

B cell differentiation; B cell receptor; Glycosylation; Pre B cell receptor

Indexed keywords

B LYMPHOCYTE RECEPTOR; LECTIN; MANNOSE; OLIGOSACCHARIDE;

ACCESSORY CELL; ANIMAL CELL; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; BIOTINYLATION; CELL COUNT; CELL DIFFERENTIATION; FLOW CYTOMETRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOGLOBULIN MU-CHAINS; IMMUNOPRECIPITATION; MANNOSE; MANNOSE-BINDING LECTINS; MICE; OLIGOSACCHARIDES; PRE-B CELL RECEPTORS; PRECURSOR CELLS, B-LYMPHOID;

MURINAE;

EID: 78649515398     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.07.005     Document Type: Article

References (23)

1. Benschop R.J., Cambier J. B cell development: signal transduction by antigen receptors and their surrogates. Curr. Opin. Immunol. 1999, 11:143-151.
2. Bergman Y., Haimovich J. Characterization of a carcinogen-induced murine B cell line of C3H/eB origin. Eur. J. Immunol. 1977, 7:413-417.
3. Brouns G.S., de Vries E., Neefjes J.J., Borst J. Assembled pre-B cell receptor complexes are retained in the endoplasmic reticulum by a mechanism that is not selective for the pseudo-light chain. J. Biol. Chem. 1996, 271:19272-19278.
4. Fang T., Smith B.P., Roman C.A. Conventional and surrogate light chains differentially regulate Ig μ and Dμ heavy chain maturation and surface expression. J. Immunol. 2001, 167:3846-3857.
5. Gauthier L., Rossi B., Roux F., Termine E., Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells in pre-BCR triggering. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13014-13019.
6. Haran-Gera N., Peled A., Canaani E., Caspi Y., Haimovich J., Shaf D., Resnkitzky B., Brightman K., Fan H. The effects of passive anti-viral immunotherapy in AKR mice. II. Susceptibility to B cell lymphomagenesis. Leukemia 1995, 9:1940-1947.
7. preB/λ5 surrogate light chain on the surface of μ heavy chain-negative early precursor B cell lines. J. Exp. Med. 1993, 178:469-478.
8. Maes J., Caspi Y., Rougeon F., Haimovich J., Goodhardt M. Secondary V(D)J rearrangement and B cell receptor-mediated down regulation of recombination activating gene-2 expression in a murine B cell line. J. Immunol. 2000, 165:703-709.
9. Meffre E., Casellas R., Nussenzweig M.C. Antibody regulation of B cell development. Nat. Immunol. 2000, 1:379-385.
10. Meffre E., Schaefer A., Wardemann H., Wilson P., Davis E., Nussenzweig M.C. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 2004, 199:145-150.
11. Muljo S.A., Schlissel M.S. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol. Rev. 2000, 175:80-93.
12. Nickel W., Seedorf M. Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol. 2008, 24:287-308.
13. Nishimoto N., Kubagawa H., Ohno T., Gartland G.L., Stankovic A.K., Cooper M.D. Normal pre-B cells express a receptor complex of μ heavy chains and surrogate light-chain proteins. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:6284-6288.
14. Ohnishi K., Melchers F. The nonimmunoglobulin portion of λ5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol. 2003, 4:849-856.
15. Rabinovich E., Bar-Nun S., Amity R., Shachar I., Gur B., Taya M., Haimovich J. Different assembly species of IgM are directed to distinct degradation sites along the secretory pathway. J. Biol. Chem. 1993, 268:24145-24148.
16. Radcliffe C.M., Arnold J.N., Suter D.M., Wormald M.R., Harvey D.J., Royle L., Mimura Y., Kimura Y., Sim R.B., Inoges S., Rodriguez-Calvillo M., Zabalegui N., Lopez-Diaz de Cerio A., Potter K.N., Mockridge C.I., Dwek R.A., Bernard M., Rudd P.M., Stevenson F.K. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J. Biol. Chem. 2007, 282:7405-7415.
17. Schuh W., Meister S., Roth E., Jäck H.M. Signaling and cell surface expression of a μH chain in the absence of λ5: a paradigm revisited. J. Immunol. 2003, 171:3343-3347.
18. Su Y.W., Flemming A., Wossning T., Hobeika E., Reth M., Jumaa H. Identification of a pre-BCR lacking surrogate light chain. J. Exp. Med. 2003, 198:1699-1706.
19. Taya M., Haimovich J. immunotherapy of B lymphoma by anti-idiotype antibodies: characterization of variant tumor cells appearing a long time after the initial tumor inoculation. Cancer Immunol. Immunother. 1991, 34:43-48.
20. Uemura K., Yokota Y., Kozutsumi Y., Kawasaki T. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes. J. Biol. Chem. 1996, 271:4581-4584.
21. Vettermann C., Hermann K., Jäck H.M. Powered by pairing: the surrogate light chain amplifies immunoglobulin heavy chain signaling and pre-selects the antibody repertoire. Semin. Immunol. 2006, 18:44-55.
22. Vettermann C., Hermann K., Albert C., Roth E., Bösl M., Jäck H.M. A unique role for the λ5 nonimmunoglobulin tail in early B lymphocyte development. J. Immunol. 2008, 181:3232-3242.
23. Wiest D.L., Burgess W.H., McKean D., Kearse K.P., Singer A. The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotypic-independent CD3 complexes. EMBO J. 1995, 14:3425-3433.